Serum's proposal to manufacture vaccine against omicron for test and analysis, gets a DGCI nod
The Drugs Controller General of India (DCGI) has approved Serum Institute of India?s proposal to manufacture a vaccine against omicron variant of coronavirus for examination, test and analysis.
Serum News | 09/02/2022 | By Darshana | 171
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy